Cellosaurus logo
expasy logo

Cellosaurus PEA7-1-6D (CVCL_B6D1)

[Text][XML][JSON]
Cell line name PEA7-1-6D
Accession CVCL_B6D1
Resource Identification Initiative To cite this cell line use: PEA7-1-6D (RRID:CVCL_B6D1)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1809.
Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50138.
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Donor information: Established from a healthy donor infected with Pseudomonas aeruginosa.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_B6D4 (HH-1)CVCL_B6D2 (P7E9C7)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Transformed cell line
Publications

Patent=EP0305960A2
Susumu Iwasa, Yuzo Ichimori, Masato Kuriyama;
A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use.
Patent number EP0305960A2, 08-Mar-1989

PubMed=1369279; DOI=10.1007/BF00148811
Susumu Honda, Yuzo Ichimori, Susumu Iwasa;
A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.
Cytotechnology 4:59-68(1990)

Patent=EP0336405B1
Susumu Iwasa, Masato Kuriyama, Kimitake Okazaki, Yukio Toyoda;
Anti-human cancer protein complexes, their production and use.
Patent number EP0336405B1, 13-Jan-1993

Cross-references
Encyclopedic resources Wikidata; Q112129501
Entry history
Entry creation17-Mar-2022
Last entry update29-Jun-2023
Version number6